- Home
- WALD vs SAGE Comparison
WALD vs SAGE Comparison
Compare WALD & SAGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WALD
- SAGE
- Stock Information
- Founded
- WALD 1988
- SAGE 2010
- Country
- WALD United States
- SAGE United States
- Employees
- WALD N/A
- SAGE N/A
- Industry
- WALD Package Goods/Cosmetics
- SAGE Biotechnology: Pharmaceutical Preparations
- Sector
- WALD Consumer Discretionary
- SAGE Health Care
- Exchange
- WALD Nasdaq
- SAGE Nasdaq
- Market Cap
- WALD 291.5M
- SAGE 571.1M
- IPO Year
- WALD 2021
- SAGE 2014
- Fundamental
- Price
- WALD $2.49
- SAGE $9.15
- Analyst Decision
- WALD Strong Buy
- SAGE Hold
- Analyst Count
- WALD 5
- SAGE 18
- Target Price
- WALD $5.16
- SAGE $9.89
- AVG Volume (30 Days)
- WALD 183.3K
- SAGE 3.4M
- Earning Date
- WALD 08-26-2025
- SAGE 07-30-2025
- Dividend Yield
- WALD N/A
- SAGE N/A
- EPS Growth
- WALD N/A
- SAGE N/A
- EPS
- WALD N/A
- SAGE N/A
- Revenue
- WALD $273,868,000.00
- SAGE $47,404,000.00
- Revenue This Year
- WALD $14.78
- SAGE $101.71
- Revenue Next Year
- WALD $15.84
- SAGE $42.30
- P/E Ratio
- WALD N/A
- SAGE N/A
- Revenue Growth
- WALD 25.55
- SAGE N/A
- 52 Week Low
- WALD $1.98
- SAGE $4.62
- 52 Week High
- WALD $4.74
- SAGE $13.47
- Technical
- Relative Strength Index (RSI)
- WALD 49.37
- SAGE 66.98
- Support Level
- WALD $2.44
- SAGE $9.10
- Resistance Level
- WALD $2.56
- SAGE $9.36
- Average True Range (ATR)
- WALD 0.18
- SAGE 0.12
- MACD
- WALD -0.00
- SAGE -0.07
- Stochastic Oscillator
- WALD 33.33
- SAGE 26.56
About WALD Waldencast plc
Waldencast PLC is a beauty and wellness operating platform. The company is organized into two reportable segments namely Obagi Skincare and Milk Makeup. The company generates the majority of its revenue from the Obagi Medical segment. The Obagi Medical segment is engaged in developing, marketing, and selling skin health products. The Milk Makeup segment includes developing, marketing, and selling cosmetics, skincare, and other beauty products. Geographically the company generates the majority of its revenue from North America region.
About SAGE Sage Therapeutics Inc.
Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines. The company is targeting diseases and disorders of the brain with three key focus areas: depression, neurology and neuropsychiatry; also targeting two critical central nervous system, or CNS, receptor systems, GABA and NMDA. Its products ZURZUVAE is a medicine for the treatment of postpartum depression, or PPD, in adults, and ZULRESSO is a CIV injection for the treatment of postpartum depression in individuals 15 years old and older. It also has other drugs in its pipeline such as SAGE-324, Dalzanemdor (SAGE-718) among others.